Calico Biosystems
Lausanne · Founded 2024
About Calico Biosystems
Calico Biosystems is a cancer testing platform that predicts the clinical efficacy of anticancer medications in the pre-clinical stage.
Company Facts
- Founded: 2024
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $167.5K
- Last round: Grant (Jun 2024)
- Website: https://calicobiosystems.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/calico-biosystems-203289 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.